FDA panel: Thumbs up on alefacept

Silver Spring, Md. - The FDA Dermatologic and Ophthalmic AdvisoryCommittee, by an 8-2 vote, on May 23 recommended approval of alefacept,a systemic drug for the treatment of chronic plaque psoriasis.

Related Videos
© 2023 MJH Life Sciences

All rights reserved.